Effects of FT011 in Systemic Sclerosis

Clinical trial NCT04647890 · COMPLETED

Trial details

NCT number: NCT04647890
Sponsor: Certa Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic Scleroderma, Diffuse Sclerosis, Systemic

Start date: 2021-07-19
Primary completion: 2022-10-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.